Progesterone (CED0000698)

Record Information
Version1.0
Creation Date2014-08-29 06:01:46 UTC
Update Date2026-05-14 16:37:30 UTC
SynCED IDCED0000698
Secondary Accession Numbers
  • CHEM003204
  • T3D4244
Identification
Common NameProgesterone
ClassSmall Molecule
Description
Progesterone belongs to the pregnane steroids, a subclass of steroids and steroid derivatives within the organic compounds. This endogenous steroid hormone (PMC12782534 ) has the chemical formula C21H30O2 and an average molecular weight of 314.46 g/mol. At room temperature, it exists as a solid. It is categorized as a lipid and lipid-like molecule. Progesterone functions as a progestin, progesterone receptor agonist, human metabolite, and antioxidant (PMC6968520 ), and it acts as an anti-inflammatory agent (PMC12105142 ) and drug (PMC6388372 ). Industrially, it is used as a softener and conditioner and is found in plastics such as polyamide, high-density polyethylene, and low-density polyethylene. The compound is detected in various tissues, including the placenta, gonads, testes, prostate, adipose tissue, fibroblasts, neurons, and platelets. It interacts with 29 protein targets, including the progesterone receptor (PGR), estrogen receptor (ESR1), mineralocorticoid receptor (NR3C2), and steroid 17-alpha-hydroxylase/17,20 lyase (CYP17A1). Exposure routes include oral, vaginal, topical, transdermal, subcutaneous, and intramuscular administration. It has been recorded in sources such as drinking water, food preservation, perfumes within detergents and soaps, and healthcare products including progestogens. Health effects associated with progesterone include increased anxiety (PMC12562881 ), increased depression (PMC12562881 ), increased asthma (PMC9025817 ), infertility (PMC3215335 ), and breast cancer (PMC8909997 ). It is associated with decreased blood pressure (PMC11625001 ) and is decreased in the blood of individuals with obesity (PMC11282738 ). While linked to endometriosis (PMC8774370 ) and increased endometriosis (PMC10046867 ), it is also used as a treatment for endometriosis (PMC3215335 ) and may be decreased in the condition (PMC10046867 ). Therapeutic effects are noted for osteoporosis (PMC12897635 ), inflammation (PMC7978485 ), ischemic stroke (PMC12486939 ), and traumatic brain injury (PMC12486939 ).
Contaminant Type
  • Animal Toxin
  • Contraceptive Agent
  • Drug
  • Ester
  • Food Toxin
  • Metabolite
  • Natural Compound
  • Organic Compound
  • Progestin
Chemical Structure
Synonyms
ValueSource
(S)-4-Pregnene-3,20-dioneChEBI
(S)-Pregn-4-en-3,20-dioneChEBI
(S)-ProgesteroneChEBI
17alpha-ProgesteroneChEBI
4-Pregnene-3,20-dioneChEBI
AgolutinChEBI
AkrolutinChEBI
Corpus luteum hormoneChEBI
CrinoneChEBI
Delta(4)-Pregnene-3,20-dioneChEBI
GelbkoerperhormonChEBI
LuteohormoneChEBI
ProgesteronChEBI
PrometriumKegg
17a-ProgesteroneGenerator
17Α-progesteroneGenerator
Δ(4)-pregnene-3,20-dioneGenerator
3,20-Pregnene-4HMDB
4-Pregnen-3,20-dioneHMDB
beta-ProgesteroneHMDB
Bio-lutonHMDB
CIDRHMDB
ColprosteroneHMDB
CorlutinHMDB
CorlutinaHMDB
CorluviteHMDB
CorporinHMDB
Crinone progesterone gelHMDB
CurretabHMDB
CyclogestHMDB
CyclogesterinHMDB
D4-Pregnene-3,20-dioneHMDB
DelalutinHMDB
DuraprogenHMDB
EstimaHMDB
FlavolutanHMDB
FologenonHMDB
GesterolHMDB
Gesterol 100HMDB
Gesterol 50HMDB
GestironHMDB
GestoneHMDB
GestormoneHMDB
GestronHMDB
GlanducorpinHMDB
GynlutinHMDB
GynolutonHMDB
GynolutoneHMDB
HormoflaveineHMDB
HormolutonHMDB
Hydroxyprogesterone caproateHMDB
Hydroxyprogesterone caproic acidHMDB
LingusorbsHMDB
Lipo-lutinHMDB
LucorteumHMDB
Lucorteum solHMDB
LugesteronHMDB
Luteal hormoneHMDB
Luteocrin normaleHMDB
LuteodynHMDB
LuteoganHMDB
LuteolHMDB
LuteopurHMDB
LuteosanHMDB
LuteostabHMDB
LuteovisHMDB
LuteumHMDB
LutexHMDB
LutidonHMDB
LutociclinaHMDB
Lutocuclin mHMDB
LutocyclinHMDB
Lutocyclin mHMDB
LutocylinHMDB
LutocylolHMDB
LutoformHMDB
LutogylHMDB
LutrenHMDB
LutromoneHMDB
MembrettesHMDB
MethylpregnoneHMDB
MPAHMDB
NalutronHMDB
PercutacrineHMDB
Percutacrine luteiniqueHMDB
PiapononHMDB
PranoneHMDB
Pregn-4-en-3,20-dioneHMDB
Pregn-4-ene-3,20-dioneHMDB
Pregnene-3,20-dioneHMDB
PregnenedioneHMDB
PrimolutHMDB
ProchieveHMDB
ProgeffikHMDB
ProgekanHMDB
ProgestanHMDB
ProgestasertHMDB
ProgesterolHMDB
ProgesteronumHMDB
ProgestinHMDB
ProgestogelHMDB
ProgestolHMDB
ProgestonHMDB
ProgestoneHMDB
ProgestosolHMDB
ProgestronHMDB
ProgestronolHMDB
ProjestajectHMDB
ProletsHMDB
ProlidonHMDB
ProlutinHMDB
ProlutonHMDB
ProlutoneHMDB
ProntogestHMDB
ProtormoneHMDB
SyngesteroneHMDB
SyngestretsHMDB
Synovex SHMDB
SyntolutanHMDB
UtrogestHMDB
UtrogestanHMDB
VitarrineHMDB
Progesterone, (13 alpha,17 alpha)-(+-)-isomerHMDB
Progesterone, (17 alpha)-isomerHMDB
Progesterone, (9 beta,10 alpha)-isomerHMDB
Chemical FormulaC21H30O2
Average Molecular Mass314.462 g/mol
Monoisotopic Mass314.225 g/mol
CAS Registry Number57-83-0
IUPAC Name(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
Traditional Name(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
SMILES[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
InChI IdentifierInChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1
InChI KeyRJKFOVLPORLFTN-LEKSSAKUSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassPregnane steroids
Direct ParentGluco/mineralocorticoids, progestogins and derivatives
Alternative Parents
Substituents
  • Progestogin-skeleton
  • 20-oxosteroid
  • Oxosteroid
  • 3-oxosteroid
  • 3-oxo-delta-4-steroid
  • Delta-4-steroid
  • Cyclohexenone
  • Cyclic ketone
  • Ketone
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginEndogenous
Cellular Locations
  • Cytoplasm
  • Endoplasmic reticulum
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue Locations
  • Adipose Tissue
  • Fibroblasts
  • Gonads
  • Neuron
  • Placenta
  • Platelet
  • Prostate
  • Testes
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic Effects
  • transparent colour ?
  • opaque colour ?
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point121°C
Boiling PointNot Available
Solubility8.81 mg/L (at 25°C)
Predicted Properties
PropertyValueSource
Water Solubility0.0055 g/LALOGPS
logP3.58ALOGPS
logP4.15ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)18.92ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area34.14 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity92.71 m³·mol⁻¹ChemAxon
Polarizability37.26 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0fbc-5910000000-422e38df6de7e8b0a4b7Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0fbc-5910000000-385f45345742235da8e0Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-024l-6923000000-639c7405f69825de7f90Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0229-2941000000-1e075d8489b79cf4e34aNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0229-3963000000-f35e3d9faf6b2ee87465Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0fbc-5910000000-422e38df6de7e8b0a4b7Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0fbc-5910000000-385f45345742235da8e0Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0f6x-2910000000-1baafb91a3e0b988caa7Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-000g-1590000000-3ebb52b90c541e38c0b4Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-1009000000-0f8b7c3e6c2265c3889fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-8900000000-0b0167121b798e7e7534Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9400000000-881510cbcecd9cb61f4fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-024l-6923000000-639c7405f69825de7f90Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0229-2941000000-1e075d8489b79cf4e34aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0950000000-ca28d8dfdf780c201716Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-857f6720dd17fb2547d1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-3930000000-fda87095285a83b85ad5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kb-7955000000-a22f06eac940cd4f753dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0139000000-6b47f75a44df3e20fa3bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0950000000-b26d04d179294aa67cc7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0920000000-d0a3365efe1f8a589564Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05aj-0910000000-61d7a07e6be85600e1f1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0009000000-67c6f0147801f0ece957Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05mk-8956000000-aa5fe992c41261b62fbfNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-6910000000-5e26497eb2d0150a30acNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-8900000000-7ca6fd15f0ccc18bfa31Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9700000000-523fe1ad11bfcbb46f85Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-054k-9400000000-e3d581bd8685e1d3f35dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-5900000000-8a409fe2508f58822f8aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-8900000000-fc9280df2a7dee451abbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0290000000-0f9dd31ff254325dd522Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0290000000-b59a04537c8d112aa2abNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0190000000-b5fed26f17626a75c34cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0190000000-58920a9d93488054d8d5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-002k-0190000000-5f1ba0db62e0ade93f30Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0229000000-c83c60bdf0d3b91077c9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-5921000000-fccf432e6f84ed354acdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-4921100000-41abb61d58cd1d7a0f7cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9500000000-6524a8c90e5955a9c196Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9800000000-3fb0c3f137ed2dd1743dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9834000000-c6f9672023aada37e0fdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-8900000000-55fdc9b81b40d2cfec04Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0290000000-ec7ff9092b95b4e2f81fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-7900000000-286121f39777e52df7dfNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0920000000-d0a3365efe1f8a589564Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-054k-9400000000-633a19654a92c0585d62Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0950000000-b26d04d179294aa67cc7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9600000000-a6b819f14967bdea5fb6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0009000000-ad0e61b1ad75306402e7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0920000000-c591f7bbfb9ac18aa6ceNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05mk-9847000000-67eb75a2c3458a44700bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kb-8946000000-bae759c43ab9888786f5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0009000000-3b232dcdb5a13acd9108Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-5962000000-cbfbdadf6fdb3f82c156Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-7900000000-ef5a133b2317028e3042Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-8922000000-19772a7006340411ff17Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-1109000000-b1bb92d3fcdc15435c3fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0960000000-9cdea149ab6d208a69e9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05aj-0910000000-61d7a07e6be85600e1f1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9500000000-ee25931896aedfe7a904Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-9800000000-d1dffe362a6c3854f810Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0920000000-b387394252288b90e678Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05aj-0910000000-320ae85ab8df062ea143Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052b-9600000000-b6d8683dbcd4fba193ccNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4j-5900000000-2dd6ccb1f6279492f29eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0139000000-f6f1c7fb45abe2076f25Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0aba-0960000000-f42c77716f68be83a732Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-054k-9400000000-41e4b7fae267606973b6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0290000000-14bfed926eba3a4f484dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0269000000-9aa25f8d44bc44ee4d4cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-06dj-0491000000-c312ac322a549be24facNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0pbc-2290000000-859101eb546be9ddc938Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0019000000-e021f799bd2d232a0592Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0049000000-55066424591bf87a4a49Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0002-1090000000-e9387b8ab692f5ef9083Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0039000000-d1494504168c82f83e26Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-066s-0592000000-acaf5c8822c490f87479Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ab9-1910000000-45b586c0f8e563a24c9cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0009000000-2514638890974c4f71f3Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0069000000-1f21875f16b4e06d1a5aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03dl-2093000000-88d9ab594c0eaba84d6cNot AvailableView Spectrum
MSMS Spectrumsplash10-006x-7931000000-f6ad83adccd7e016fa29Not AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
2778.0 Log mg/kg [1600:4900]RatLD50oralpredictedNot AvailableNot Available
40.0 mg/kg-day RatNOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
15.0 mg/kg-day RatLOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
15.0 mg/kg-day RatNOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
0.435 mg/kg-day RatNOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityProgesterone shares the pharmacological actions of the progestins. Progesterone binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Progesterone will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. In women who have adequate endogenous estrogen, progesterone transforms a proliferative endometrium into a secretory one. Progesterone is essential for the development of decidual tissue and is necessary to increase endometrial receptivity for implantation of an embryo. Once an embryo has been implanted, progesterone acts to maintain the pregnancy. Progesterone also stimulates the growth of mammary alveolar tissue and relaxes uterine smooth muscle. It has little estrogenic and androgenic activity.
Carcinogenicity (IARC Classification)2B, possibly carcinogenic to humans. (21)
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
blood pressureAssociated With?decreaseNot AvailablePMC11625001
inflammationHas Therapeutic Effect OnNot AvailableNot AvailablePMC7978485
inflammationAssociated With?decreaseNot AvailablePMC11202752
inflammationAssociated With?Not AvailableNot AvailablePMC9100592 , PMC12007591
cancerAssociated With?Not AvailableCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC12036885 , PMC11012526
cancerAssociated With?increaseCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC13204802
Alzheimer's diseaseAssociated With?increaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC9820491
Alzheimer's diseaseAssociated With?decreaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC9483202
dementiaAssociated With?increaseA cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior. (DO)PMC5187886
breast cancerAssociated With?Not AvailableA breast cancer that has material basis in abnormally proliferating cells derives from epithelial cells. (DO)PMC8909997 , PMC9183204
breast cancerAssociated With?increaseA breast cancer that has material basis in abnormally proliferating cells derives from epithelial cells. (DO)PMC12036885 , PMC7013395
breast cancerIs Biomarker OfNot AvailableA breast cancer that has material basis in abnormally proliferating cells derives from epithelial cells. (DO)PMC10805021
insomniaAssociated With?inverseA disorder characterized by difficulty in falling asleep and/or remaining asleep. (NCI CTCAE)PMC12376051 , PMC12376051
insomniaAssociated With?increaseA disorder characterized by difficulty in falling asleep and/or remaining asleep. (NCI CTCAE)PMC12376051 , PMC12376051
insomniaAssociated With?Not AvailableA disorder characterized by difficulty in falling asleep and/or remaining asleep. (NCI CTCAE)PMC12376051 , PMC12376051
type 2 diabetes mellitusAssociated With?Not AvailableNot AvailablePMC10871592 , PMC11900157
type 2 diabetes mellitusAssociated With?increaseNot AvailablePMC11545986 , PMC12851039
infertilityAssociated With?Not AvailableA disorder characterized by the inability to reproduce by natural means.PMC3215335 , PMC8969127
infertilityNot AvailableNot AvailableA disorder characterized by the inability to reproduce by natural means.PMC13014894
infertilityAssociated With?decreaseA disorder characterized by the inability to reproduce by natural means.PMC9471549
osteoporosisHas Therapeutic Effect OnNot AvailableA disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. (NCI CTCAE)PMC12897635
fatigueAssociated With?increaseA disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. (NCI CTCAE)PMC11134286
gestational diabetesAssociated With?increaseA disorder, occurring in pregnant women, characterized by hyperglycemia.PMC8536136
asthmaAssociated With?increaseA bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has symptom recurring periods of wheezing (a whistling sound while breathing), has symptom chest tightness, has symptom shortness of breath, has symptom mucus production and has symptom coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety. (DO)PMC9025817 , PMC4048857
ischemic strokeHas Therapeutic Effect OnNot AvailableNot AvailablePMC12486939
ischemic strokeAssociated With?increaseNot AvailablePMC13108057
strokeAssociated With?increaseNot AvailablePMC2921812 , PMC3521879
strokeAssociated With?Not AvailableNot AvailablePMC9617770
bleedingNot AvailableNot AvailableA losing of blood as a result of injury oir illness.PMC12884572
endometrial cancerNot AvailableNot AvailableA uterine cancer that is located in tissues lining the uterus. (DO)PMC13084854
endometrial cancerAssociated With?Not AvailableA uterine cancer that is located in tissues lining the uterus. (DO)PMC12317513
endometrial cancerHas Therapeutic Effect OnNot AvailableA uterine cancer that is located in tissues lining the uterus. (DO)PMC8719328
headacheAssociated With?increaseA disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve. (NCI CTCAE)PMC11134286
headacheAssociated With?Not AvailableA disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve. (NCI CTCAE)PMC10932431
weight gainAssociated With?Not AvailableA finding characterized by an increase in overall body weight; for pediatrics, greater than the baseline growth curve. (NCI CTCAE)PMC13084854 , PMC6376977
anxietyAssociated With?increaseA disorder characterized by apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus. (NCI CTCAE)PMC12562881 , PMC12562881
depressionAssociated With?increaseNot AvailablePMC12562881 , PMC12562881
obesityDecreased in Blood IndecreaseA disorder characterized by having a high amount of body fat. (NCI CTCAE)PMC11282738
nauseaAssociated With?Not AvailableA disorder characterized by a queasy sensation and/or the urge to vomit. (NCI CTCAE)PMC11340200 , PMC11340200
nauseaAssociated With?increaseA disorder characterized by a queasy sensation and/or the urge to vomit. (NCI CTCAE)PMC11134286
vomitingAssociated With?Not AvailableA disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. (NCI CTCAE)PMC11340200 , PMC11340200
traumatic brain injuryHas Therapeutic Effect OnNot AvailableA severe physical injury to the brain usually due to a violent blow or jolt to the head or body.PMC12486939
myocardial infarctionAssociated With?increaseA disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area. (NCI CTCAE)PMC3521879 , PMC13108057
urinary incontinenceAssociated With?Not AvailableA disorder characterized by inability to control the flow of urine from the bladder. (NCI CTCAE)PMC10181412
thrombosisAssociated With?Not AvailableA formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system.PMC13108057
ovarian cancerAssociated With?increaseA female reproductive organ cancer that is located in the ovary. (DO)PMC5743449 , PMC12155410
miscarriageNot AvailableNot AvailableA natural death of an embryo or fetus before it is able to survive independently.PMC11766822
miscarriageAssociated With?decreaseA natural death of an embryo or fetus before it is able to survive independently.PMC8184480
EndometriosisAssociated With?Not AvailableEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC10046867 , PMC12317513
EndometriosisDecreased in Blood IndecreaseEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC10046867
EndometriosisNot AvailableNot AvailableEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC3215335 , PMC12025187
EndometriosisAssociated With?increaseEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC8774370
hypospadiasAssociated With?Not AvailableNot AvailablePMC8502235
hypospadiasElevated in Blood InincreaseNot AvailablePMC5928321 , PMC5928321
Toxic encephalopathyNot AvailableNot AvailableNot AvailablePMC10525378
brain ischemiaNot AvailableNot AvailableA disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage. (NCI CTCAE)PMC10636063
migraineAssociated With?increaseA brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing. (DO)PMC8119594
pre-eclampsiaAssociated With?increaseNot AvailablePMC6144938
pre-eclampsiaDecreased in Blood IndecreaseNot AvailablePMC6144938
endometrial hyperplasiaNot AvailableNot AvailableNot AvailablePMC13301012 , PMC12565450
endometrial hyperplasiaHas Therapeutic Effect OnNot AvailableNot AvailablePMC8719328
endometrial hyperplasiaAssociated With?increaseNot AvailablePMC13204802
anovulationAssociated With?decreaseNot AvailablePMC6568019
anovulationAssociated With?Not AvailableNot AvailablePMC13055502
placental insufficiencyNot AvailableNot AvailableNot AvailablePMC11455966
placental insufficiencyAssociated With?Not AvailableNot AvailablePMC9100592
anxiety disorderAssociated With?Not AvailableNot AvailablePMC9820491
anxiety disorderHas Therapeutic Effect OnNot AvailableNot AvailablePMC6617135
retinitis pigmentosaHas Therapeutic Effect OnNot AvailableRetinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Symptoms include trouble seeing at night and decreased peripheral vision (side vision). As peripheral vision worsens, people may experience "tunnel vision". Complete blindness is uncommon. Onset of symptoms is generally gradual and often in childhood. Retinitis pigmentosa is generally inherited from a person's parents. It is one of the most common forms of inherited retinal degeneration. There are multiple genes that, when mutated, can cause the retinitis pigmentosa phenotype. Inheritance patterns of RP have been identified as autosomal dominant, autosomal recessive, X-linked, and maternally (mitochondrially) acquired, and are dependent on the specific RP gene mutations present in the parental generation. Up to 150 mutations have been reported to date in the opsin gene associated with the RP. Autosomal recessive inheritance patterns of RP have been identified in at least 45 genes. Mutations in four pre-mRNA splicing factors are known to cause autosomal dominant retinitis pigmentosa. These are PRPF3 (human PRPF3 is HPRPF3; also PRP3), PRPF8, PRPF31 and PAP1. The underlying mechanism involves the progressive loss of rod photoreceptor cells in the back of the eye. Retinitis pigmentosa is the leading cause of inherited blindness, with approximately 1/4,000 individuals experiencing the non-syndromic form (without other clinical findings) of their disease within their lifetime. It is estimated that 1.5 million people worldwide are currently affected. (Wikipedia)PMC7283457
viral infectious diseaseAssociated With?Not AvailableNot AvailablePMC4332593
sleep disorderAssociated With?inverseNot AvailablePMC12376051 , PMC12376051
sleep disorderAssociated With?Not AvailableNot AvailablePMC12376051 , PMC12376051
sleep disorderAssociated With?increaseNot AvailablePMC12376051 , PMC12376051
Oxidative StressDecreased in Blood InNot AvailableNot AvailablePMC13134263
cardiovascular disorderHas Therapeutic Effect OnNot AvailableNot AvailablePMC12897635
MortalityHas Therapeutic Effect OnNot AvailableNot AvailablePMC3943200
Cerebral edemaHas Therapeutic Effect OnNot AvailableNot AvailablePMC3943200
nervous system disorderHas Therapeutic Effect OnNot AvailableNot AvailablePMC6968520
depressive disorderAssociated With?Not AvailableNot AvailablePMC6376977
Premature birthNot AvailableNot AvailableNot AvailablePMC6144938 , PMC4154493
Premature birthHas Therapeutic Effect OnNot AvailableNot AvailablePMC4154493
Premature birthAssociated With?increaseNot AvailablePMC9097261
constipation disorderAssociated With?Not AvailableNot AvailablePMC6376977
NeoplasmsAssociated With?Not AvailableNot AvailablePMC8909997
FertilityAssociated With?Not AvailableNot AvailablePMC12198667
infectious diseaseAssociated With?increaseNot AvailablePMC13028863
bone fractureHas Therapeutic Effect OnNot AvailableNot AvailablePMC5743449
Hot flashesDecreased in Blood InNot AvailableNot AvailablePMC4867120
Hot flashesAssociated With?Not AvailableNot AvailablePMC8187273 , PMC10181412
Hot flashesHas Therapeutic Effect OnNot AvailableNot AvailablePMC13346774
substance dependenceAssociated With?Not AvailableNot AvailablePMC8675278
venous thromboembolismAssociated With?increaseNot AvailablePMC13108057 , PMC10852998
Mental deteriorationAssociated With?decreaseNot AvailablePMC9820491 , PMC9820491
atypical endometrial hyperplasiaAssociated With?Not AvailableNot AvailablePMC8281489
Reproductive HealthAssociated With?Not AvailableNot AvailablePMC12198667
AstheniaAssociated With?Not AvailableNot AvailablePMC6376977
ThromboembolismAssociated With?increaseNot AvailablePMC13108057
primary ovarian insufficiencyNot AvailableNot AvailableNot AvailablePMC6366956
MemoryAssociated With?Not AvailableNot AvailablePMC9820491
Night sweatsAssociated With?Not AvailableNot AvailablePMC10181412
AtrophyAssociated With?Not AvailableNot AvailablePMC9331312
MenorrhagiaAssociated With?Not AvailableNot AvailablePMC11856463
MetrorrhagiaAssociated With?Not AvailableNot AvailablePMC9617770
Respiratory Distress SyndromeHas Therapeutic Effect OnNot AvailableNot AvailablePMC4154493
Pregnancy OutcomeHas Therapeutic Effect OnNot AvailableNot AvailablePMC12827195
tumor of uterusAssociated With?increaseNot AvailablePMC13064891
precocious pubertyAssociated With?Not AvailableNot AvailablePMC5581466
thrombotic diseaseAssociated With?increaseNot AvailablePMC3521879
female infertilityAssociated With?Not AvailableNot AvailablePMC12317513
dysmenorrheaAssociated With?Not AvailableNot AvailablePMC11856463
Venous thrombosisAssociated With?increaseNot AvailablePMC9617770
MenopauseNot AvailableNot AvailableNot AvailablePMC12565450
spinal cord injuryHas Therapeutic Effect OnNot AvailableNot AvailablePMC12486939
Pregnancy RateAssociated With?increaseNot AvailablePMC13014894
uterine fibroidAssociated With?Not AvailableNot AvailablePMC12077057
Vaginal drynessHas Therapeutic Effect OnNot AvailableNot AvailablePMC13346774
Vaginal drynessAssociated With?Not AvailableNot AvailablePMC10181412
Gestational Weight GainAssociated With?increaseNot AvailablePMC8336629
premature laborAssociated With?Not AvailableNot AvailablePMC12007591
Litter SizeAssociated With?increaseNot AvailablePMC13125080
Decreased libidoAssociated With?decreaseNot AvailablePMC10932431
endometriosis of ovaryAssociated With?increaseNot AvailablePMC12465827
ovarian hyperstimulation syndromeAssociated With?increaseNot AvailablePMC11379559
endometriosis of uterusAssociated With?increaseNot AvailablePMC8953406
progestogen hypersensitivityAssociated With?Not AvailableNot AvailablePMC10299550
ContraceptionAssociated With?Not AvailableNot AvailablePMC13108057
peliosis hepatisAssociated With?Not AvailableNot AvailablePMC10417184
Fragmented sleepAssociated With?Not AvailableNot AvailablePMC12376051
Exposure Sources
Source IDSourceSectorReference
CEDs000013Soil?Soil serves as a critical medium for plant growth and sustains various ecological functions; however, it can become a reservoir for synthetic chemical contamination.Agriculture & land managementPMC12474287 , PMC12474287
CEDs000051Surface water?Surface water can serve as a significant vector for the introduction of synthetic chemical contaminants into aquatic ecosystems.Aquatic systems & sedimentsPMC11554600 , PMC6388372
CEDs000115Drinking water?Drinking water can be a medium for synthetic chemical contamination, often originating from various industrial processes and agricultural practices.Drinking water & water supplyNot Available
CEDs000116Tap water?Tap water can be a potential source of synthetic chemical contamination due to various industrial processes and agricultural runoff.Drinking water & water supplyPMC10574876
CEDs000320Progestogens?Progestogens are synthetic hormones used primarily in hormone replacement therapy, contraceptive formulations, and veterinary medicine.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000322Progestogens and estrogens in combination?Progestogens and estrogens are synthetic hormones commonly used in various therapeutic applications, including hormonal contraception, hormone replacement therapy, and veterinary medicine.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000483WWTP effluent?Wastewater treatment plant (WWTP) effluent can serve as a significant source of synthetic chemical contamination in the environment.Wastewater, sanitation & biosolidsPMC9720157
CEDs000484Activated sludge?Activated sludge refers to a mixture of microorganisms and organic matter used in the biological treatment of wastewater.Wastewater, sanitation & biosolidsPMC13400670
CEDs000498Ladders?Ladders, commonly used in various construction and maintenance activities, can become a source of synthetic chemical contamination due to the materials and coatings applied during their manufacture and use.Building & ConstructionPubChem
CEDs000505Amplifiers?Amplifiers, commonly used in various electronic devices to enhance signal strength, can be a source of synthetic chemical contamination due to the materials and processes involved in their production and disposal.Electrical & Electronic EquipmentPubChem
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000516Electric Hearing Aids?Electric hearing aids are small electronic devices designed to amplify sound for individuals with hearing loss.Electrical & Electronic EquipmentPubChem
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000525Line Transmission Systems?Line Transmission Systems, commonly used for the distribution of electrical energy, can be a source of synthetic chemical contamination through the insulation materials and coatings utilized in their construction.Electrical & Electronic EquipmentPubChem
CEDs000530Radio Transmission Systems?Radio transmission systems utilize a variety of synthetic chemicals in their manufacturing and maintenance processes.Electrical & Electronic EquipmentPubChem
CEDs000537Television Systems?Television systems can be a source of synthetic chemical contamination due to the various materials and components used in their manufacture and operation.Electrical & Electronic EquipmentPubChem
CEDs000539Video Games?Video games, through their production and disposal processes, can be a source of synthetic chemical contamination.Electrical & Electronic EquipmentPubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000578Making Cigars?The process of making cigars involves several steps, including the cultivation of tobacco, fermentation, and the application of various additives to enhance flavor and preservation.Industrial manufacturing & chemical processingPubChem
CEDs000580Manufacture Preparation Of Tobacco Products?The manufacture and preparation of tobacco products involve various processes that can result in the introduction of synthetic chemicals into the environment.Industrial manufacturing & chemical processingPubChem
CEDs000596Acaricides?Acaricides are synthetic chemicals specifically designed to target and control mite populations that can damage crops and plants.Agriculture & land managementPubChem
CEDs000600Herbicides And Algicides?Herbicides and algicides are synthetic chemicals primarily used to control unwanted plants and algae in various environments.Agriculture & land managementPubChem
CEDs000604Pest Attractants?Pest attractants are synthetic chemicals designed to lure specific pests for monitoring or control purposes.Agriculture & land managementPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000609Aftershave?Aftershave is a grooming product typically used to soothe and protect the skin following shaving.Personal care & cosmeticsPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000613Depilatories?Depilatories are products designed to remove unwanted hair through the application of synthetic chemicals that break down the protein structure of hair, facilitating its removal.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000617Lip Care Products?Lip care products, including lipsticks, balms, and glosses, often contain a variety of synthetic chemicals such as parabens, phthalates, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000678Nitrogenous Fertilisers?Nitrogenous fertilizers are synthetic chemical compounds primarily used to enhance plant growth by supplying essential nitrogen, a crucial nutrient for photosynthesis and protein synthesis.Agriculture & land managementPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000688Glass Coatings?Glass coatings are synthetic chemical formulations applied to glass surfaces to enhance properties such as durability, UV resistance, and aesthetic appeal.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs00833Agricultural WaterAgriculture & land managementPMC6388372
CEDs00929Red SoilAgriculture & land managementPMC12474287
CEDs01091Pharmaceutical FormulationsHealthcare, pharmaceuticals & veterinary productsPMC12565450
CEDs01115HospitalHealthcare, pharmaceuticals & veterinary productsPMC6388372
CEDs01148MilkFood, food processing & cookwarePMC7764623 , PMC13352057
CEDs01152Food ChainFood, food processing & cookwarePMC5568942
CEDs01153Breast MilkFood, food processing & cookwarePMC10831895
CEDs01162Dairy ProductsFood, food processing & cookwarePMC13352057
CEDs01249Milk FatFood, food processing & cookwarePMC10831895 , PMC13170835
CEDs01881Epoxy ResinsIndustrial manufacturing & chemical processingPMC5445781
CEDs01931Olfactory BulbIndustrial manufacturing & chemical processingPMC12844654
CEDs02161Packaging WasteWaste management, landfill & incinerationPMC9695542
CEDs02232DrinkingDrinking water & water supplyPMC6388372
CEDs02248Municipal WaterDrinking water & water supplyPMC6388372
CEDs02255WaterAquatic systems & sedimentsPMC7540170 , PMC7540170
CEDs02264SedimentAquatic systems & sedimentsPMC5896310
CEDs02268Water SamplesAquatic systems & sedimentsPMC9343308 , PMC9343308
CEDs02270RiverAquatic systems & sedimentsPMC6388372
CEDs02286LakeAquatic systems & sedimentsPMC6388372 , PMC8313683
CEDs02845CosmeticsPersonal care & cosmeticsPMC5581466
CEDs03009Waste WaterWastewater, sanitation & biosolidsPMC9343308 , PMC11554600
CEDs03053Hospital WastewaterWastewater, sanitation & biosolidsPMC10574876
CEDs03073Treated WastewaterWastewater, sanitation & biosolidsPMC9720157
Pathways
36 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Progesterone receptor structureClick to view 3D structureProgesterone receptorP06401HumansKnownNot Available
TAR DNA-binding protein 43 structureClick to view 3D structureTAR DNA-binding protein 43Q13148HumansKnownNot Available
Click to view 3D structureMonoacylglycerol lipase ABHD2P08910HumansKnownNot Available
Click to view 3D structureDelta(24)-sterol reductaseQ15392HumansKnownNot Available
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansKnownNot Available
Cytochrome P450 3A5 structureClick to view 3D structureCytochrome P450 3A5P20815HumansKnownNot Available
Glucocorticoid receptor structureClick to view 3D structureGlucocorticoid receptorP04150HumansKnownNot Available
Sulfotransferase 2A1 structureClick to view 3D structureSulfotransferase 2A1Q06520HumansKnownNot Available
Aromatase structureClick to view 3D structureAromataseP11511HumansKnownNot Available
Prolactin structureClick to view 3D structureProlactinP01236HumansKnownNot Available
Click to view 3D structure3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1P14060HumansKnownNot Available
Nuclear receptor subfamily 1 group I member 2 structureClick to view 3D structureNuclear receptor subfamily 1 group I member 2O75469HumansKnownNot Available
Steroid 21-hydroxylase structureClick to view 3D structureSteroid 21-hydroxylaseP08686HumansKnownNot Available
Dehydrogenase/reductase SDR family member 11 structureClick to view 3D structureDehydrogenase/reductase SDR family member 11Q6UWP2HumansKnownNot Available
Nuclear receptor coactivator 3 structureClick to view 3D structureNuclear receptor coactivator 3Q9Y6Q9HumansKnownNot Available
Cytochrome P450 1B1 structureClick to view 3D structureCytochrome P450 1B1Q16678HumansKnownNot Available
Neutrophil elastase structureClick to view 3D structureNeutrophil elastaseP08246HumansKnownNot Available
17-beta-hydroxysteroid dehydrogenase type 1 structureClick to view 3D structure17-beta-hydroxysteroid dehydrogenase type 1P14061HumansKnownNot Available
Aldo-keto reductase family 1 member C1 structureClick to view 3D structureAldo-keto reductase family 1 member C1Q04828HumansKnownNot Available
Corticosteroid-binding globulin structureClick to view 3D structureCorticosteroid-binding globulinP08185HumansPredicted (SEA)
Prediction Confidence Score
0.767
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
21
E-value
0.0778492
Androgen receptor structureClick to view 3D structureAndrogen receptorP15207Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.755
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
73
E-value
0.0778492
Sex hormone-binding globulin structureClick to view 3D structureSex hormone-binding globulinP04278HumansPredicted (SEA)
Prediction Confidence Score
0.746
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
33
E-value
0.0778492
Glucocorticoid receptor structureClick to view 3D structureGlucocorticoid receptorP04150HumansPredicted (SEA)
Prediction Confidence Score
0.697
Applicability Domain
1.0
Statistical Significance
7.00e-05
Supporting Reference Compounds
154
E-value
0.544945
Mineralocorticoid receptor structureClick to view 3D structureMineralocorticoid receptorP08235HumansKnownNot Available
Click to view 3D structureProgesterone receptorQ690N0Bos taurusPredicted (SEA)
Prediction Confidence Score
0.697
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
40
E-value
0.0778492
Click to view 3D structureCytochrome P450 1A1P00185RatKnownNot Available
Androgen receptor structureClick to view 3D structureAndrogen receptorP10275HumansPredicted (SEA)
Prediction Confidence Score
0.691
Applicability Domain
1.0
Statistical Significance
2.00e-05
Supporting Reference Compounds
146
E-value
0.155698
Cytochrome P450 1A2 structureClick to view 3D structureCytochrome P450 1A2P05177HumansKnownNot Available
Mineralocorticoid receptor structureClick to view 3D structureMineralocorticoid receptorP08235HumansPredicted (SEA)
Prediction Confidence Score
0.666
Applicability Domain
1.0
Statistical Significance
2.00e-05
Supporting Reference Compounds
74
E-value
0.155698
Androgen receptor structureClick to view 3D structureAndrogen receptorP19091Mus musculusPredicted (SEA)
Prediction Confidence Score
0.622
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
19
E-value
0.0778492
Progesterone receptor structureClick to view 3D structureProgesterone receptorP06401HumansPredicted (SEA)
Prediction Confidence Score
0.571
Applicability Domain
1.0
Statistical Significance
2.30e-04
Supporting Reference Compounds
119
E-value
1.79053
Steroid 17-alpha-hydroxylase/17,20 lyase structureClick to view 3D structureSteroid 17-alpha-hydroxylase/17,20 lyaseP05093HumansPredicted (SEA)
Prediction Confidence Score
0.565
Applicability Domain
0.792
Statistical Significance
9.00e-05
Supporting Reference Compounds
69
E-value
0.700643
3-oxo-5-alpha-steroid 4-dehydrogenase 2 structureClick to view 3D structure3-oxo-5-alpha-steroid 4-dehydrogenase 2P31213HumansPredicted (SEA)
Prediction Confidence Score
0.562
Applicability Domain
0.792
Statistical Significance
6.00e-05
Supporting Reference Compounds
19
E-value
0.467095
Estrogen receptor structureClick to view 3D structureEstrogen receptorP03372HumansPredicted (SEA)
Prediction Confidence Score
0.558
Applicability Domain
1.0
Statistical Significance
3.20e-04
Supporting Reference Compounds
201
E-value
2.49118
Click to view 3D structure3-oxo-5-alpha-steroid 4-dehydrogenase 1P18405HumansPredicted (SEA)
Prediction Confidence Score
0.548
Applicability Domain
0.792
Statistical Significance
3.00e-05
Supporting Reference Compounds
14
E-value
0.233548
Click to view 3D structureSolute carrier family 22 member 3O88446Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.535
Applicability Domain
0.776
Statistical Significance
1.00e-05
Supporting Reference Compounds
3
E-value
0.0778492
G-protein coupled bile acid receptor 1 structureClick to view 3D structureG-protein coupled bile acid receptor 1Q8TDU6HumansPredicted (SEA)
Prediction Confidence Score
0.523
Applicability Domain
1.0
Statistical Significance
5.70e-04
Supporting Reference Compounds
54
E-value
4.43741
Click to view 3D structureSolute carrier family 22 member 2Q9R0W2Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.506
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
14
E-value
0.0778492
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.498
Applicability Domain
1.0
Statistical Significance
0.0025
Supporting Reference Compounds
562
E-value
19.4623
Click to view 3D structureSolute carrier organic anion transporter family member 1A1P46720Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.474
Applicability Domain
0.723
Statistical Significance
7.00e-05
Supporting Reference Compounds
10
E-value
0.544945
Aromatase structureClick to view 3D structureAromataseP11511HumansPredicted (SEA)
Prediction Confidence Score
0.469
Applicability Domain
0.723
Statistical Significance
5.70e-04
Supporting Reference Compounds
127
E-value
4.43741
Click to view 3D structure11-beta-hydroxysteroid dehydrogenase type 2P80365HumansPredicted (SEA)
Prediction Confidence Score
0.469
Applicability Domain
0.692
Statistical Significance
1.90e-04
Supporting Reference Compounds
32
E-value
1.47914
Click to view 3D structureC-8 sterol isomerase ERG2P32352Baker's yeastPredicted (SEA)
Prediction Confidence Score
0.464
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
20
E-value
0.0778492
Click to view 3D structure3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1P14060HumansPredicted (SEA)
Prediction Confidence Score
0.452
Applicability Domain
0.484
Statistical Significance
1.70e-04
Supporting Reference Compounds
3
E-value
1.32344
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)
Prediction Confidence Score
0.45
Applicability Domain
1.0
Statistical Significance
0.0083
Supporting Reference Compounds
1245
E-value
64.9263
Bile salt export pump structureClick to view 3D structureBile salt export pumpO95342HumansPredicted (SEA)
Prediction Confidence Score
0.432
Applicability Domain
1.0
Statistical Significance
3.70e-04
Supporting Reference Compounds
104
E-value
2.88042
Solute carrier family 22 member 1 structureClick to view 3D structureSolute carrier family 22 member 1O15245HumansPredicted (SEA)
Prediction Confidence Score
0.428
Applicability Domain
1.0
Statistical Significance
2.00e-05
Supporting Reference Compounds
30
E-value
0.155698
Click to view 3D structureCalcium-activated potassium channel subunit alpha-1Q08460MouseKnownNot Available
Progesterone receptor structureClick to view 3D structureProgesterone receptorP06401HumansKnownNot Available
Androgen receptor structureClick to view 3D structureAndrogen receptorP10275HumansKnownNot Available
Estrogen receptor structureClick to view 3D structureEstrogen receptorP03372HumansKnownNot Available
Glucocorticoid receptor structureClick to view 3D structureGlucocorticoid receptorP04150HumansKnownNot Available
Nuclear receptor subfamily 1 group I member 2 structureClick to view 3D structureNuclear receptor subfamily 1 group I member 2O75469HumansKnownNot Available
Mineralocorticoid receptor structureClick to view 3D structureMineralocorticoid receptorP08235HumansKnownNot Available
ATP-dependent translocase ABCB1 structureClick to view 3D structureATP-dependent translocase ABCB1P08183HumansKnownNot Available
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase structureClick to view 3D structure3-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseQ15125HumansKnownNot Available
Broad substrate specificity ATP-binding cassette transporter ABCG2 structureClick to view 3D structureBroad substrate specificity ATP-binding cassette transporter ABCG2Q9UNQ0HumansKnownNot Available
Alpha-1-acid glycoprotein 1 structureClick to view 3D structureAlpha-1-acid glycoprotein 1P02763HumansKnownNot Available
Aryl hydrocarbon receptor structureClick to view 3D structureAryl hydrocarbon receptorP35869HumansKnownNot Available
Bile salt export pump structureClick to view 3D structureBile salt export pumpO95342HumansKnownNot Available
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansKnownNot Available
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansKnownNot Available
Fatty acid-binding protein, intestinal structureClick to view 3D structureFatty acid-binding protein, intestinalP12104HumansKnownNot Available
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansKnownNot Available
Lanosterol 14-alpha demethylase structureClick to view 3D structureLanosterol 14-alpha demethylaseQ16850HumansKnownNot Available
Sex hormone-binding globulin structureClick to view 3D structureSex hormone-binding globulinP04278HumansKnownNot Available
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansKnownNot Available
Solute carrier family 22 member 1 structureClick to view 3D structureSolute carrier family 22 member 1O15245HumansKnownNot Available
Solute carrier family 22 member 2 structureClick to view 3D structureSolute carrier family 22 member 2O15244HumansKnownNot Available
Solute carrier family 22 member 3 structureClick to view 3D structureSolute carrier family 22 member 3O75751HumansKnownNot Available
Steroid 17-alpha-hydroxylase/17,20 lyase structureClick to view 3D structureSteroid 17-alpha-hydroxylase/17,20 lyaseP05093HumansKnownNot Available
Sterol O-acyltransferase 1 structureClick to view 3D structureSterol O-acyltransferase 1P35610HumansKnownNot Available
Cytochrome P450 2C19 structureClick to view 3D structureCytochrome P450 2C19P33261HumansKnownNot Available
Bile acid receptor structureClick to view 3D structureBile acid receptorQ96RI1HumansKnownNot Available
Click to view 3D structureTranslocator proteinP30536HumansKnownNot Available
Cytochrome P450 2C18 structureClick to view 3D structureCytochrome P450 2C18P33260HumansKnownNot Available
Equilibrative nucleoside transporter 1 structureClick to view 3D structureEquilibrative nucleoside transporter 1Q99808HumansKnownNot Available
Concentrations
Not Available
External Links
DrugBank IDDB00396
HMDB IDHMDB0001830
FooDB IDFDB001871
Phenol Explorer IDNot Available
KNApSAcK IDC00034649
BiGG ID34898
BioCyc IDPROGESTERONE
METLIN ID402
PDB IDNot Available
Wikipedia LinkProgesterone
Chemspider ID5773
ChEBI ID17026
PubChem Compound ID5994
Kegg Compound IDC00410
YMDB IDNot Available
ECMDB IDM2MDB005073
References
Synthesis Reference

Nejib M. Nasraoui, Alain Piasco, “Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them.” U.S. Patent US5223492, issued May, 1971.

MSDSLink
General References
  1. Allen WM: THE ISOLATION OF CRYSTALLINE PROGESTIN. Science. 1935 Aug 2;82(2118):89-93. [PubMed: 17747122]
  2. Allen WM: Progesterone: how did the name originate? South Med J. 1970 Oct;63(10):1151-5. [PubMed: 4922128]
  3. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S18-33. [PubMed: 15135772]
  4. Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA: Progesterone receptors regulate gallbladder motility. J Surg Res. 1988 Dec;45(6):505-12. [PubMed: 3184927]
  5. Schwarz S, Pohl P: Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology. 1992 Feb;55(2):174-82. [PubMed: 1620285]
  6. Afsar NA, Barakzai Q, Adil SN: Effect of a 'progestin only' contraceptive on platelet aggregation in a Pakistani set of population. J Ayub Med Coll Abbottabad. 2005 Jul-Sep;17(3):21-5. [PubMed: 16320790]
  7. Moguilewsky M, Tournemine C: The antiandrogen anandron potentiates the castrating effect of the LH-RH agonist buserelin in the rat. Am J Clin Oncol. 1988;11 Suppl 2:S148-51. [PubMed: 3149454]
  8. Wang C, Swerdloff RS: Male hormonal contraception. Am J Obstet Gynecol. 2004 Apr;190(4 Suppl):S60-8. [PubMed: 15105800]
  9. Landi N, Manfredini D, Lombardi I, Casarosa E, Bosco M: 17-beta-estradiol and progesterone serum levels in temporomandibular disorder patients. Minerva Stomatol. 2004 Nov-Dec;53(11-12):651-60. [PubMed: 15894940]
  10. Classen-Linke I, Alfer J, Krusche CA, Chwalisz K, Rath W, Beier HM: Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids. 2000 Oct-Nov;65(10-11):763-71. [PubMed: 11108887]
  11. Callaghan MJ, Russell AJ, Woollatt E, Sutherland GR, Sutherland RL, Watts CK: Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene. 1998 Dec 31;17(26):3479-91. [PubMed: 10030672]
  12. Casey ML, MacDonald PC, Andersson S: 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest. 1994 Nov;94(5):2135-41. [PubMed: 7962560]
  13. Lueprasitsakul P, Longcope C: Aromatase activity of human adipose tissue stromal cells: effects of thyroid hormones and progestogens. Proc Soc Exp Biol Med. 1990 Sep;194(4):337-41. [PubMed: 2167478]
  14. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E: Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005 May 18;97(10):755-65. [PubMed: 15900045]
  15. Oliveira RL, Aldrighi JM, Gebara OE, Rocha TR, D'Amico E, Rosano GM, Ramires JA: Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. Int J Cardiol. 2005 Mar 30;99(3):449-54. [PubMed: 15771927]
  16. Magee JA, Chang LW, Stormo GD, Milbrandt J: Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology. 2006 Jan;147(1):590-8. Epub 2005 Oct 6. [PubMed: 16210365]
  17. Pierson-Mullany LK, Lange CA: Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol. 2004 Dec;24(24):10542-57. [PubMed: 15572662]
  18. Baum LW: Sex, hormones, and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2005 Jun;60(6):736-43. [PubMed: 15983176]
  19. Seibert B, Gunzel P: Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna. Contraception. 1994 Apr;49(4):303-33. [PubMed: 8013217]
  20. Payer AF, Meyer WJ 3rd, Walker PA: The ultrastructural response of human Leydig cells to exogenous estrogens. Andrologia. 1979;11(6):423-36. [PubMed: 532984]
  21. International Agency for Research on Cancer (2014). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. - http://monographs.iarc.fr/index.php